Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI

Antonio J Vallejo-Vaz, Sarah Bray, Guillermo Villa, Julia Brandts, Gaia Kiru, Jennifer Murphy, Maciej Banach, Stefano De Servi, Dan Gaita, Ioanna Gouni-Berthold, G Kees Hovingh, Jacek J Jozwiak, J Wouter Jukema, Robert Gabor Kiss, Serge Kownator, Helle K Iversen, Vincent Maher, Luis Masana, Alexander Parkhomenko, André PeetersPiers Clifford, Katarina Raslova, Peter Siostrzonek, Stefano Romeo, Dimitrios Tousoulis, Charalambos Vlachopoulos, Michal Vrablik, Alberico L Catapano, Neil R Poulter, Kausik K Ray*, DA VINCI Study Investigators, Helle Klingenberg Iversen (Medlem af forfattergruppering)

*Corresponding author af dette arbejde
8 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science